Eisai authorized to sell Alzheimer's drug in China

Eisai and Biogen have now received approval for their new Alzheimer's drug, Leqembi, in China. Around 10 million people in the People's Republic suffer from the disease. The drug is not yet sold in Europe.

Last updated: 24. July 2025